Follow
Gianfranco Balboni
Gianfranco Balboni
Verified email at unica.it
Title
Cited by
Cited by
Year
Synthesis, in vitro antiproliferative activity, and DNA-binding properties of hybrid molecules containing pyrrolo [2, 1-c][1, 4] benzodiazepine and minor-groove-binding …
PG Baraldi, G Balboni, B Cacciari, A Guiotto, S Manfredini, R Romagnoli, ...
Journal of medicinal chemistry 42 (25), 5131-5141, 1999
1681999
δ Opioidmimetic Antagonists: Prototypes for Designing a New Generation of Ultraselective Opioid Peptides
S Salvadori, M Attila, G Balboni, C Bianchi, SD Bryant, O Crescenzi, ...
Molecular medicine 1, 678-689, 1995
1541995
Peptidic delta opioid receptor agonists produce antidepressant-like effects in the forced swim test and regulate BDNF mRNA expression in rats
MM Torregrossa, EM Jutkiewicz, HI Mosberg, G Balboni, SJ Watson, ...
Brain research 1069 (1), 172-181, 2006
1232006
Evaluation of the Dmt− tic pharmacophore: conversion of a potent δ-opioid receptor antagonist into a potent δ agonist and ligands with mixed properties
G Balboni, R Guerrini, S Salvadori, C Bianchi, D Rizzi, SD Bryant, ...
Journal of medicinal chemistry 45 (3), 713-720, 2002
1212002
The chemokine Bv8/prokineticin 2 is up-regulated in inflammatory granulocytes and modulates inflammatory pain
E Giannini, R Lattanzi, A Nicotra, AF Campese, P Grazioli, I Screpanti, ...
Proceedings of the National Academy of Sciences 106 (34), 14646-14651, 2009
1112009
δ‐, but not µ‐, opioid receptor stabilizes K+ homeostasis by reducing Ca2+ influx in the cortex during acute hypoxia
D Chao, A Bazzy‐Asaad, G Balboni, Y Xia
Journal of cellular physiology 212 (1), 60-67, 2007
1112007
Design, synthesis, DNA binding, and biological evaluation of water-soluble hybrid molecules containing two pyrazole analogues of the alkylating cyclopropylpyrroloindole (CPI …
PG Baraldi, G Balboni, MG Pavani, G Spalluto, MA Tabrizi, ED Clercq, ...
Journal of medicinal chemistry 44 (16), 2536-2543, 2001
1082001
Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary δ opioid antagonist activity
S Salvadori, G Balboni, R Guerrini, R Tomatis, C Bianchi, SD Bryant, ...
Journal of medicinal chemistry 40 (19), 3100-3108, 1997
1081997
Anxiolytic-and antidepressant-like activities of H-Dmt-Tic-NH-CH (CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist
R Vergura, G Balboni, B Spagnolo, E Gavioli, DG Lambert, J McDonald, ...
Peptides 29 (1), 93-103, 2008
1062008
Potent δ-Opioid Receptor Agonists Containing the Dmt− Tic Pharmacophore
G Balboni, S Salvadori, R Guerrini, L Negri, E Giannini, Y Jinsmaa, ...
Journal of medicinal chemistry 45 (25), 5556-5563, 2002
1012002
Indole derivatives as multifunctional drugs: Synthesis and evaluation of antioxidant, photoprotective and antiproliferative activity of indole hydrazones
M Demurtas, A Baldisserotto, I Lampronti, D Moi, G Balboni, S Pacifico, ...
Bioorganic chemistry 85, 568-576, 2019
992019
Further studies on the Dmt-Tic pharmacophore: hydrophobic substituents at the C-terminus endow δ antagonists to manifest μ agonism or μ antagonism
S Salvadori, R Guerrini, G Balboni, C Bianchi, SD Bryant, PS Cooper, ...
Journal of medicinal chemistry 42 (24), 5010-5019, 1999
791999
Triazine compounds as antagonists at Bv8-prokineticin receptors
G Balboni, I Lazzari, C Trapella, L Negri, R Lattanzi, E Giannini, A Nicotra, ...
Journal of medicinal chemistry 51 (23), 7635-7639, 2008
752008
Agonists at the δ‐opioid receptor modify the binding of µ‐receptor agonists to the µ–δ receptor hetero‐oligomer
N Kabli, N Martin, T Fan, T Nguyen, A Hasbi, G Balboni, BF O'Dowd, ...
British journal of pharmacology 161 (5), 1122-1136, 2010
682010
Synthesis and pharmacological activity of deltorphin and dermorphin-related glycopeptides
R Tomatis, M Marastoni, G Balboni, R Guerrini, A Capasso, L Sorrentino, ...
Journal of medicinal chemistry 40 (18), 2948-2952, 1997
681997
Activation of DOR Attenuates Anoxic K+ Derangement via Inhibition of Na+ Entry in Mouse Cortex
D Chao, A Bazzy-Asaad, G Balboni, S Salvadori, Y Xia
Cerebral Cortex 18 (9), 2217-2227, 2008
662008
Design of δ-opioid peptide antagonists for emerging drug applications
LH Lazarus, SD Bryant, PS Cooper, R Guerrini, G Balboni, S Salvadori
Drug Discovery Today 3 (6), 284-294, 1998
581998
Conformational dynamics of Kir3. 1/Kir3. 2 channel activation via δ-opioid receptors
M Richard-Lalonde, K Nagi, N Audet, R Sleno, M Amraei, M Hogue, ...
Molecular pharmacology 83 (2), 416-428, 2013
572013
Controlling the activation of the B v8/prokineticin system reduces neuroinflammation and abolishes thermal and tactile hyperalgesia in neuropathic animals
D Maftei, V Marconi, F Florenzano, LA Giancotti, M Castelli, S Moretti, ...
British journal of pharmacology 171 (21), 4850-4865, 2014
552014
6-N,N-Dimethylamino-2,3-naphthalimide:  A New Environment-Sensitive Fluorescent Probe in δ- and μ-Selective Opioid Peptides
ME Vįzquez, JB Blanco, S Salvadori, C Trapella, R Argazzi, SD Bryant, ...
Journal of medicinal chemistry 49 (12), 3653-3658, 2006
552006
The system can't perform the operation now. Try again later.
Articles 1–20